| 1. |
- Bäcklund, Nils, et al.
(författare)
-
Salivary cortisol and cortisone in diagnosis of Cushing's syndrome - a comparison of six different analytical methods
- 2023
-
Ingår i: Clinical Chemistry and Laboratory Medicine. - : Walter de Gruyter. - 1434-6621 .- 1437-4331. ; 61:10, s. 1780-1791
-
Tidskriftsartikel (refereegranskat)abstract
- Objectives: Salivary cortisol and cortisone at late night and after dexamethasone suppression test (DST) are increasingly used for screening of Cushing's syndrome (CS). We aimed to establish reference intervals for salivary cortisol and cortisone with three liquid chromatography-tandem mass spectrometry (LC-MS/MS) techniques and for salivary cortisol with three immunoassays (IAs), and evaluate their diagnostic accuracy for CS.Methods: Salivary samples at 08:00 h, 23:00 h and 08:00 h after a 1-mg DST were collected from a reference population (n=155) and patients with CS (n=22). Sample aliquots were analyzed by three LC-MS/MS and three IA methods. After establishing reference intervals, the upper reference limit (URL) for each method was used to calculate sensitivity and specificity for CS. Diagnostic accuracy was evaluated by comparing ROC curves.Results: URLs for salivary cortisol at 23:00 h were similar for the LC-MS/MS methods (3.4-3.9 nmol/L), but varied between IAs: Roche (5.8 nmol/L), Salimetrics (4.3 nmol/L), Cisbio (21.6 nmol/L). Corresponding URLs after DST were 0.7-1.0, and 2.4, 4.0 and 5.4 nmol/L, respectively. Salivary cortisone URLs were 13.5-16.6 nmol/L at 23:00 h and 3.0-3.5 nmol/L at 08:00 h after DST. All methods had ROC AUCs =0.96.Conclusions: We present robust reference intervals for salivary cortisol and cortisone at 08:00 h, 23:00 h and 08:00 h after DST for several clinically used methods. The similarities between LC-MS/MS methods allows for direct comparison of absolute values. Diagnostic accuracy for CS was high for all salivary cortisol and cortisone LC-MS/MS methods and salivary cortisol IAs evaluated.
|
|
| 2. |
|
|
| 3. |
- Eriksson, Jan W., et al.
(författare)
-
Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation : the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study
- 2008
-
Ingår i: Hypertension. - : American Heart Association. - 0194-911X .- 1524-4563. ; 52:6, s. 1030-1037
-
Tidskriftsartikel (refereegranskat)abstract
- Treatment with angiotensin II receptor blockers is associated with lower risk for the development of type 2 diabetes mellitus compared with thiazide diuretics. The Mechanisms for the Diabetes Preventing Effect of Candesartan Study addressed insulin action and secretion and body fat distribution after treatment with candesartan, hydrochlorothiazide, and placebo. Twenty-six nondiabetic, abdominally obese, hypertensive patients were included in a multicenter 3-way crossover trial, and 22 completers (by predefined criteria; 10 men and 12 women) were included in the analyses. They underwent 12-week treatment periods with candesartan (C; 16 to 32 mg), hydrochlorothiazide (H; 25 to 50 mg), and placebo (P), respectively, and the treatment order was randomly assigned and double blinded. Intravenous glucose tolerance tests and euglycemic hyperinsulinemic (56 mU/m(2) per minute) clamps were performed. Intrahepatic and intramyocellular and extramyocellular lipid content and subcutaneous and visceral abdominal adipose tissue were measured using proton magnetic resonance spectroscopy and MRI. Insulin sensitivity (M-value) was reduced following H versus C and P (6.07+/-2.05, 6.63+/-2.04, and 6.90+/-2.10 mg/kg of body weight per minute, mean+/-SD; P
|
|
| 4. |
- Erlinge, D., et al.
(författare)
-
Bivalirudin versus Heparin Monotherapy in Myocardial Infarction
- 2017
-
Ingår i: New England Journal of Medicine. - : Massachusetts Medical Society. - 0028-4793 .- 1533-4406. ; 377:12, s. 1132-1142
-
Tidskriftsartikel (refereegranskat)abstract
- Background The comparative efficacy of various anticoagulation strategies has not been clearly established in patients with acute myocardial infarction who are undergoing percutaneous coronary intervention (PCI) according to current practice, which includes the use of radial-artery access for PCI and administration of potent P2Y12 inhibitors without the planned use of glycoprotein IIb/IIIa inhibitors. Methods In this multicenter, randomized, registry-based, open-label clinical trial, we enrolled patients with either ST-segment elevation myocardial infarction (STEMI) or non-STEMI (NSTEMI) who were undergoing PCI and receiving treatment with a potent P2Y12 inhibitor (ticagrelor, prasugrel, or cangrelor) without the planned use of glycoprotein IIb/IIIa inhibitors. The patients were randomly assigned to receive bivalirudin or heparin during PCI, which was performed predominantly with the use of radial-artery access. The primary end point was a composite of death from any cause, myocardial infarction, or major bleeding during 180 days of follow-up. Results A total of 6006 patients (3005 with STEMI and 3001 with NSTEMI) were enrolled in the trial. At 180 days, a primary end-point event had occurred in 12.3% of the patients (369 of 3004) in the bivalirudin group and in 12.8% (383 of 3002) in the heparin group (hazard ratio, 0.96; 95% confidence interval [CI], 0.83 to 1.10; P=0.54). The results were consistent between patients with STEMI and those with NSTEMI and across other major subgroups. Myocardial infarction occurred in 2.0% of the patients in the bivalirudin group and in 2.4% in the heparin group (hazard ratio, 0.84; 95% CI, 0.60 to 1.19; P=0.33), major bleeding in 8.6% and 8.6%, respectively (hazard ratio, 1.00; 95% CI, 0.84 to 1.19; P=0.98), definite stent thrombosis in 0.4% and 0.7%, respectively (hazard ratio, 0.54; 95% CI, 0.27 to 1.10; P=0.09), and death in 2.9% and 2.8%, respectively (hazard ratio, 1.05; 95% CI, 0.78 to 1.41; P=0.76). Conclusions Among patients undergoing PCI for myocardial infarction, the rate of the composite of death from any cause, myocardial infarction, or major bleeding was not lower among those who received bivalirudin than among those who received heparin monotherapy. (Funded by the Swedish Heart-Lung Foundation and others; VALIDATE-SWEDEHEART ClinicalTrialsRegister.eu number, 2012-005260-10 ; ClinicalTrials.gov number, NCT02311231 .).
|
|
| 5. |
|
|
| 6. |
|
|
| 7. |
- Azimi Mousolou, Vahid, et al.
(författare)
-
Entanglement duality in spin-spin interactions
- 2022
-
Ingår i: Physical Review A: covering atomic, molecular, and optical physics and quantum information. - : American Physical Society (APS). - 2469-9926 .- 2469-9934. ; 106:3
-
Tidskriftsartikel (refereegranskat)abstract
- We examine entanglement of thermal states for spin-1/2 dimers in external magnetic fields. Entanglement transition in the temperature-magnetic-field plane demonstrates a duality in spin-spin interactions. This identifies a pair of dual categories of symmetric and antisymmetric dimers with each category classified into toric entanglement classes. The entanglement transition line is preserved from each toric entanglement class to its dual toric class. The toric classification is an indication of the topological signature of the entanglement, which bring about topological stability that could be relevant for quantum information processing.
|
|
| 8. |
- Azimi Mousolou, Vahid, et al.
(författare)
-
Hierarchy of magnon mode entanglement in antiferromagnets
- 2020
-
Ingår i: Physical Review B Condensed Matter. - : American Physical Society. - 0163-1829 .- 1095-3795. ; 102:22
-
Tidskriftsartikel (refereegranskat)abstract
- Continuous variable entanglement between magnon modes in Heisenberg antiferromagnets with Dzyaloshinskii-Moriya (DM) interaction is examined. Different bosonic modes are identified, which allows us to establish a hierarchy of magnon entanglement. We argue that entanglement between magnon modes is determined by a simple lattice-specific parameter, together with the ratio of the strengths of the DM and Heisenberg exchange interactions, and that magnon entanglement can be detected by means of quantum homodyne techniques. As an illustration of the relevance of our findings for possible entanglement experiments in the solid state, a typical antiferromagnet with the perovskite crystal structure is considered, and it is shown that long wave length magnon modes have a maximal degree of entanglement.
|
|
| 9. |
- Azimi Mousolou, Vahid, et al.
(författare)
-
Magnon-magnon entanglement and its quantification via a microwave cavity
- 2021
-
Ingår i: Physical Review B. - : American Physical Society. - 2469-9950 .- 2469-9969. ; 104:22
-
Tidskriftsartikel (refereegranskat)abstract
- Quantum magnonics is an emerging research field, with great potential for applications in magnon based hybrid systems and quantum information processing. Quantum correlation, such as entanglement, is a central resource in many quantum information protocols that naturally comes about in any study toward quantum technologies. This applies also to quantum magnonics. Here, we investigate antiferromagnetic coupling of two ferromagnetic sublattices that can have two different magnon modes. We show how this may lead to experimentally measurable bipartite continuous-variable magnon-magnon entanglement. The entanglement can be fully characterized via a single squeezing parameter or, equivalently, entanglement parameter. The clear relation between the entanglement parameter and the Einstein, Podolsky, and Rosen (EPR) function of the ground state opens up for experimental quantification magnon-magnon continuous-variable entanglement and EPR nonlocality. We propose a practical experimental realization to measure the EPR function of the ground state, in a setting that relies on magnon-photon interaction in a microwave cavity.
|
|
| 10. |
- Azimi Mousolou, Vahid, et al.
(författare)
-
Transmon probe for quantum characteristics of magnons in antiferromagnets
- 2023
-
Ingår i: Physical Review B. - : American Physical Society. - 2469-9950 .- 2469-9969. ; 108:9
-
Tidskriftsartikel (refereegranskat)abstract
- The detection of magnons and their quantum properties, especially in antiferromagnetic (AFM) materials, is a substantial step to realize many ambitious advances in the study of nanomagnetism and the development of energy efficient quantum technologies. The recent development of hybrid systems based on superconducting circuits provides the possibility to engineer quantum sensors that exploit different degrees of freedom. Here, we examine the magnon-photon-transmon hybridization based on bipartite AFM materials, which gives rise to an effective coupling between a transmon qubit and magnons in a bipartite AFM. We demonstrate how magnon modes, their chiralities, and quantum properties, such as nonlocality and two-mode magnon entanglement in bipartite AFMs, can be characterized through the Rabi frequency of the superconducting transmon qubit.
|
|
